A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

September 26, 2024

Study Completion Date

September 26, 2024

Conditions

Healthy

Interventions

DRUG

Zavegepant 10mg

intransal spray 10mg

Trial Locations (2)

Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield

Bio-Kinetic Clinicals Applications LLC DBA QPS-MO Patient Screening and Recruitment Center Center), Springfield